{"database":"iProX","file_versions":[],"scores":null,"additional":{"omics_type":["Proteomics"],"submitter":["Mianmian Liao"],"species":["Homo Sapiens"],"full_dataset_link":["http://www.iprox.org/page/project.html?id=IPX0016372000"],"submitter_email":["lmmcsq@163.com"],"submitter_affiliation":["The Affiliated Dongguan Songshan Lake Central Hospital, Guangdong Medical University"],"sample_protocol":[""],"repository":["iProX"],"data_protocol":[""],"additional_accession":[]},"is_claimable":false,"name":"Compound Phyllanthus urinaria L. combined with lenvatinib inhibits the proliferation of HepG2 cells by blocking the PI3K-Akt and complement and coagulation cascade pathways","description":"The combination of CP and lenvatinib effectively inhibits the proliferation, cloning, migration, and invasion of HepG2 liver cancer cells. This effect is related to the regulation of the PI3K/Akt and complement and coagulation cascade pathways. This study highlights the potential of CP and lenvatinib combination therapy for the treatment of advanced liver cancer.","dates":{"publication":"Wed Apr 22 00:00:00 BST 2026"},"accession":"PXD077471","cross_references":{"TAXONOMY":["9606"]}}